Clarient, Inc. (CLRT) Closes Purchase of Applied Genomics
Clarient, Inc. reported that it closed on its purchase of Applied Genomics, Inc., a private biotechnology company, in a stock deal worth $17.6 million. Applied Genomics, Inc. is headquartered in Huntsville, Alabama. “Applied Genomics and Clarient represent a strong strategic and technological fit providing for multiple proprietary tests that can be commercialized via the Clarient national footprint," said Ron Andrews, the CEO of Clarient, Inc. Clarient, Inc. acquired all the ownership interests in Applied Genomics, Inc. in exchange for 7.6 million shares of Clarient common stock. Clarient, Inc. will transfer 4.4 million shares immediately, and 3.2 million shares will be…